Patents by Inventor Michael A. Nauck

Michael A. Nauck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7569540
    Abstract: A method for improved administration of nutrient is provide. The method includes co- or separate administration of a source of nutrients, especially carbohydrates, and insulinotropic peptides and derivatives, analogs, fragments and the like. The method provides high carbohydrate nutrition while avoiding hyper- and hypo-glycemia and their attendant deleterious effects.
    Type: Grant
    Filed: May 10, 2004
    Date of Patent: August 4, 2009
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Michael A. Nauck, Fred A. Wagner
  • Patent number: 6852690
    Abstract: A composition and method for improved parenteral administration of nutrients is provided. The method comprises co-administration of nutrients, especially carbohydrates, and an insulinotropic peptide, or its derivatives, analogs, and fragments. The method and composition provide high carbohydrate nutrition while avoiding hyper- and hypoglycemia and their attendant deleterious effects.
    Type: Grant
    Filed: August 22, 1996
    Date of Patent: February 8, 2005
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Michael A. Nauck, Fred A. Wagner
  • Publication number: 20040209814
    Abstract: A method for improved administration of nutrient is provide. The method includes co- or separate administration of a source of nutrients, especially carbohydrates, and insulinotropic peptides and derivatives, analogs, fragments and the like. The method provides high carbohydrate nutrition while avoiding hyper- and hypo-glycemia and their attendant deleterious effects.
    Type: Application
    Filed: May 10, 2004
    Publication date: October 21, 2004
    Inventors: Michael A. Nauck, Fred A. Wagner
  • Publication number: 20020128181
    Abstract: A composition and method for improved parenteral administration of nutrients is provided, comprising administration of an insulinotropic peptide, or its derivatives, analogs, and fragments. GLP-1 is a preferred insulinotropic hormone. Patients who are especially suited for treatment include patients with activated counterregulatory hormones, such as would occur after trauma, accidents, and surgery.
    Type: Application
    Filed: December 28, 2000
    Publication date: September 12, 2002
    Inventors: Michael Nauck, Fred W. Wagher